{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:42:57Z","timestamp":1778863377556,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.gastha.2025.100784","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T15:02:02Z","timestamp":1756566122000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Prednisone Use Increases Hepatocellular Carcinoma Risk in Autoimmune Hepatitis Cirrhosis: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Jessica","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Hemadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pojsakorn","family":"Danpanichkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasmik","family":"Adetyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomy","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Yalda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-0925","authenticated-orcid":false,"given":"Manaf","family":"Alsudaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2025.100784_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S101440","article-title":"Autoimmune hepatitis: current challenges and future prospects","volume":"10","author":"Aizawa","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gastha.2025.100784_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2025.100784_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/jpm12060925","article-title":"Gender and autoimmune liver diseases: relevant aspects in clinical practice","volume":"12","author":"Invernizzi","year":"2022","journal-title":"J Pers Med"},{"issue":"28","key":"10.1016\/j.gastha.2025.100784_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding","volume":"8","author":"Liberal","year":"2016","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gastha.2025.100784_bib6","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.3390\/jcm12051979","article-title":"Autoimmune hepatitis and fibrosis","volume":"12","author":"Pellicano","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastha.2025.100784_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.gastha.2025.100784_bib8","series-title":"StatPearls [Internet]","article-title":"Prednisone","author":"Puckett","year":"2025"},{"issue":"2","key":"10.1016\/j.gastha.2025.100784_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance from the American Association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100784_bib10","author":"Alygizakis"},{"key":"10.1016\/j.gastha.2025.100784_bib11","series-title":"University of Athens. Compound summery-prednisone","author":"Nikiforos Alygizakis","year":"2025"},{"issue":"3","key":"10.1016\/j.gastha.2025.100784_bib12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao","year":"2019","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.gastha.2025.100784_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/j.gastro.2023.06.027","article-title":"Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study","volume":"165","author":"Reddy","year":"2023","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gastha.2025.100784_bib14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","article-title":"Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis","volume":"15","author":"Tansel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2025.100784_bib15","first-page":"311","article-title":"Hepatocellular carcinoma in autoimmune hepatitis","volume":"40","author":"Vento","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100784_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161768","article-title":"Glucocorticoid regulation of cancer development and progression","volume":"14","author":"Khadka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.gastha.2025.100784_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/1940-6207.CAPR-20-0161","article-title":"Long-term glucocorticoid use and cancer risk: a population-based cohort study in South Korea","volume":"13","author":"Oh","year":"2020","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.gastha.2025.100784_bib18","first-page":"647","article-title":"Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies","volume":"2","author":"Scheijen","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.gastha.2025.100784_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"10.1016\/j.gastha.2025.100784_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gastha.2025.100784_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2018.03.006","article-title":"Synergistic effect of oral corticosteroids use on risk of hepatocellular carcinoma in high risk populations","volume":"52","author":"Lai","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.gastha.2025.100784_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"0","key":"10.1016\/j.gastha.2025.100784_bib23","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.bbi.2012.10.022","article-title":"The influence of glucocorticoid signaling on tumor progression","volume":"30","author":"Volden","year":"2013","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.gastha.2025.100784_bib24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British society of Gastroenterology guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3350\/cmh.2020.0189","article-title":"Recent updates on the management of autoimmune hepatitis","volume":"27","author":"Komori","year":"2021","journal-title":"Clin Mol Hepatol"},{"issue":"33","key":"10.1016\/j.gastha.2025.100784_bib26","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gastha.2025.100784_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000258","article-title":"MELD, MELD 3.0, versus child score to predict mortality after acute variceal hemorrhage: a multicenter US cohort","volume":"7","author":"Buckholz","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.52.1.134","article-title":"MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study","volume":"52","author":"Botta","year":"2003","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gastha.2025.100784_bib30","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/cam4.1481","article-title":"Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the dongfeng-Tongji cohort study","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.gastha.2025.100784_bib31","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.rmed.2012.12.002","article-title":"Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer","volume":"107","author":"Lee","year":"2013","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.gastha.2025.100784_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/MCB.21.3.952-965.2001","article-title":"Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)","volume":"21","author":"Brunet","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib33","first-page":"1","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"5-6","key":"10.1016\/j.gastha.2025.100784_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000104862","article-title":"Stress and wound healing","volume":"13","author":"Christian","year":"2007","journal-title":"Neuroimmunomodulation"},{"issue":"3","key":"10.1016\/j.gastha.2025.100784_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70121","article-title":"The malignant transformation of viral hepatitis to hepatocellular carcinoma: mechanisms and interventions","volume":"6","author":"Yuan","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.gastha.2025.100784_bib36","first-page":"7","article-title":"Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma","volume":"11","author":"Manaf","year":"2025","journal-title":"Hepatoma Res"},{"issue":"7","key":"10.1016\/j.gastha.2025.100784_bib37","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gastha.2025.100784_bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1155\/2013\/981086","article-title":"Challenges in the diagnosis and management of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96342-7","article-title":"Risk of hepatocellular carcinoma and cirrhosis decompensation in a large retrospective cohort of cirrhotic patients with autoimmune hepatitis","volume":"15","author":"Tatour","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-024-03276-x","article-title":"Alpha-fetoprotein and APRI as predictive markers for patients with type C hepatitis B-related acute-on-chronic liver failure: a retrospective study","volume":"24","author":"Li","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastha.2025.100784_bib41","series-title":"Alpha fetoprotein (AFP, maternal serum alpha fetoprotein, MSAFP)","author":"Adigun","year":"2019"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s44276-024-00050-0","article-title":"Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management","volume":"2","author":"Johnson","year":"2024","journal-title":"BJC Rep"},{"issue":"6","key":"10.1016\/j.gastha.2025.100784_bib43","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2025.100784_bib44","article-title":"Use of the child pugh score in liver disease","author":"Tsoris","year":"2025","journal-title":"StatPearls"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2008-1040325","article-title":"Assessment of prognosis of cirrhosis","volume":"28","author":"Durand","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MCG.0000000000001192","article-title":"Gender differences among patients hospitalized with cirrhosis in the United States","volume":"54","author":"Rubin","year":"2020","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib47","article-title":"Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy","volume":"27","author":"Liang","year":"2022","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2025.100784_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCG.0b013e318228b781","article-title":"The impact of race\/ethnicity on the clinical epidemiology of autoimmune hepatitis","volume":"46","author":"Wong","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2025.100784_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2025.100784_bib50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:30:39Z","timestamp":1764927039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572325001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"alternative-id":["S2772572325001712"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100784","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Prednisone Use Increases Hepatocellular Carcinoma Risk in Autoimmune Hepatitis Cirrhosis: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}